Ze Mi

1.1k total citations
28 papers, 554 citations indexed

About

Ze Mi is a scholar working on Biomedical Engineering, Molecular Biology and Immunology. According to data from OpenAlex, Ze Mi has authored 28 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 7 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Ze Mi's work include Nanoplatforms for cancer theranostics (8 papers), Cancer Research and Treatments (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Ze Mi is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Cancer Research and Treatments (4 papers) and Neuroscience and Neuropharmacology Research (4 papers). Ze Mi collaborates with scholars based in China, Canada and Czechia. Ze Mi's co-authors include Pengfei Rong, Zhichao Feng, Wenhu Zhou, Mengtian Ma, Xiao Yang, Zhi-ru Zhu, Dingbin Liu, Jiahao Liu, Shuancheng Ren and Hongpei Tan and has published in prestigious journals such as Nano Letters, Journal of Neurophysiology and Chemical Engineering Journal.

In The Last Decade

Ze Mi

27 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ze Mi China 12 226 191 121 66 55 28 554
Deanne W. Sammond United States 16 309 1.4× 591 3.1× 130 1.1× 71 1.1× 99 1.8× 22 970
Shinji Shimizu Japan 13 51 0.2× 196 1.0× 85 0.7× 22 0.3× 37 0.7× 19 527
Rania Soudy Canada 17 110 0.5× 388 2.0× 19 0.2× 39 0.6× 25 0.5× 22 639
Mesut Bilgin Denmark 13 46 0.2× 535 2.8× 43 0.4× 56 0.8× 23 0.4× 26 805
Annamária Marton Hungary 13 67 0.3× 265 1.4× 16 0.1× 89 1.3× 22 0.4× 28 542
Sarah A. Buhrow United States 11 139 0.6× 347 1.8× 25 0.2× 59 0.9× 81 1.5× 24 773
Liyuan Ke China 12 123 0.5× 235 1.2× 11 0.1× 121 1.8× 29 0.5× 20 535
Kevin Chen United States 9 56 0.2× 249 1.3× 39 0.3× 27 0.4× 15 0.3× 21 502
Dion A. Daniels United Kingdom 11 167 0.7× 648 3.4× 27 0.2× 30 0.5× 28 0.5× 11 870
Nadimpalli R. S. Varma United States 14 54 0.2× 251 1.3× 19 0.2× 50 0.8× 45 0.8× 18 587

Countries citing papers authored by Ze Mi

Since Specialization
Citations

This map shows the geographic impact of Ze Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze Mi more than expected).

Fields of papers citing papers by Ze Mi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ze Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze Mi. The network helps show where Ze Mi may publish in the future.

Co-authorship network of co-authors of Ze Mi

This figure shows the co-authorship network connecting the top 25 collaborators of Ze Mi. A scholar is included among the top collaborators of Ze Mi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ze Mi. Ze Mi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jiahao, Xuan Zhang, Xiaofei Fan, et al.. (2025). Liensinine reshapes the immune microenvironment and enhances immunotherapy by reprogramming metabolism through the AMPK-HIF-1α axis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 44(1). 208–208. 3 indexed citations
2.
Tan, Hongpei, Ze Mi, Xiaoqian Ma, et al.. (2025). HSA-templated synergistic platform boosts radiotherapy via enhanced radiosensitization and ferroptosis induction. Drug Resistance Updates. 83. 101293–101293.
3.
Liu, Jiahao, Peng Liu, Hongpei Tan, et al.. (2024). Macrophages-mediated tumor accumulation and deep penetration of bismuth/manganese biomineralized nanoparticles for enhanced radiotherapy. Chinese Chemical Letters. 35(12). 109632–109632. 3 indexed citations
4.
Liu, Jiahao, Hanyu Tu, Ze Mi, et al.. (2024). Bismuth/manganese-doped carbon dots in calcium phosphate matrix: Dynamic conformational nanoparticles enhancing tumor accumulation, deep penetration, and radiosensitivity. Chemical Engineering Journal. 504. 158683–158683. 11 indexed citations
5.
Tan, Hongpei, et al.. (2024). CCDC25 suppresses clear cell renal cell carcinoma progression by LATS1/YAP-mediated regulation of the hippo pathway. Cancer Cell International. 24(1). 124–124. 3 indexed citations
6.
Lu, Shan, Ze Mi, Peng Liu, et al.. (2024). Repolarizing neutrophils via MnO2 nanoparticle-activated STING pathway enhances Salmonella-mediated tumor immunotherapy. Journal of Nanobiotechnology. 22(1). 443–443. 19 indexed citations
7.
Li, Xi, Ze Mi, Zhenguo Liu, & Pengfei Rong. (2024). SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines. Frontiers in Microbiology. 15. 1334152–1334152. 10 indexed citations
8.
Zhang, Yunshu, Xuefei Feng, Juan Chen, et al.. (2023). Controversial role of ILC3s in intestinal diseases: A novelty perspective on immunotherapy. Frontiers in Immunology. 14. 1134636–1134636. 1 indexed citations
9.
Liu, Wei, et al.. (2023). UPLC-MS/MS method for Icariin and metabolites in whole blood of C57 mice: development, validation, and pharmacokinetics study. Frontiers in Pharmacology. 14. 1195525–1195525. 3 indexed citations
10.
Liu, Jiahao, et al.. (2023). PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer. European journal of medical research. 28(1). 289–289. 3 indexed citations
11.
Tan, Hongpei, Jiahao Liu, Jing Huang, et al.. (2023). Ketoglutaric acid can reprogram the immunophenotype of triple-negative breast cancer after radiotherapy and improve the therapeutic effect of anti-PD-L1. Journal of Translational Medicine. 21(1). 462–462. 16 indexed citations
12.
Mi, Ze, Yan Qi, Jinhai Zheng, et al.. (2022). Salmonella-mediated blood‒brain barrier penetration, tumor homing and tumor microenvironment regulation for enhanced chemo/bacterial glioma therapy. Acta Pharmaceutica Sinica B. 13(2). 819–833. 54 indexed citations
13.
Ma, Xiaoqian, et al.. (2022). Extracellular Polysaccharide from Rhizopus nigricans Inhibits Hepatocellular Carcinoma via miR-494-3p/TRIM36 Axis and Cyclin E Ubiquitination. Journal of Clinical and Translational Hepatology. 10(4). 608–619. 9 indexed citations
14.
Tan, Hongpei, Mengtian Ma, Ze Mi, et al.. (2022). Preoperative Body Composition Combined with Tumor Metabolism Analysis by PET/CT Is Associated with Disease‐Free Survival in Patients with NSCLC. Contrast Media & Molecular Imaging. 2022(1). 7429319–7429319. 4 indexed citations
15.
Liu, Jiahao, Lina Guo, Ze Mi, et al.. (2022). Vascular bursts-mediated tumor accumulation and deep penetration of spherical nucleic acids for synergistic radio-immunotherapy. Journal of Controlled Release. 348. 1050–1065. 27 indexed citations
16.
17.
Di, Huixia, Ze Mi, Yan Sun, et al.. (2020). Nanozyme-assisted sensitive profiling of exosomal proteins for rapid cancer diagnosis. Theranostics. 10(20). 9303–9314. 67 indexed citations
18.
Li, Mingmin, Mengtian Ma, Zhichao Feng, et al.. (2019). Alkyne- and Nitrile-Anchored Gold Nanoparticles for Multiplex SERS Imaging of Biomarkers in Cancer Cells and Tissues. Nanotheranostics. 3(1). 113–119. 52 indexed citations
19.
20.
Ren, Shuancheng, Hui Shao, Huihui Jiang, et al.. (2014). Riluzole prevents soluble Aβ1–42oligomers-induced perturbation of spontaneous discharge in the hippocampal CA1 region of rats. Amyloid. 22(1). 36–44. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deanne W. Sammond Breakdown of academic impact, for papers by Shinji Shimizu Breakdown of academic impact, for papers by Rania Soudy Breakdown of academic impact, for papers by Mesut Bilgin Breakdown of academic impact, for papers by Annamária Marton Breakdown of academic impact, for papers by Sarah A. Buhrow Breakdown of academic impact, for papers by Liyuan Ke Breakdown of academic impact, for papers by Kevin Chen Breakdown of academic impact, for papers by Dion A. Daniels Breakdown of academic impact, for papers by Nadimpalli R. S. Varma
Rankless by CCL
2026